Retsevmo 80 mg, gélules

7680678620057 CH-67862 Kapseln

Associated product:

RETSEVMO caps 80 mg 56 pce
Retsevmo 80 mg, gélules
Retsevmo 80 mg, gélules
Retsevmo 80 mg, gélules
1 / 3
google

Article details

Package size
56
Selling units
56
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/05/2025
Summary of Product Characteristics
Français
14/05/2025
Summary of Product Characteristics
Italien
14/05/2025
Patient information leaflet
Allemand
05/05/2025
Patient information leaflet
Français
05/05/2025
Patient information leaflet
Italien
05/05/2025

Detailed composition

Substance Quantity Type Category
CAP
80.0 MG Substance Wirkstoff (Principe actif)
CAP
- Substance HNIDK
CAP
- Substance HNIDK
CAP
- Substance HNIDK
CAP
- Substance FNIDK
CAP
- Substance FIMDK
CAP
- Substance HNIDK
CAP
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
CAP
- Substance HNIDK
CAP
- Substance FTODK

Reimbursement information

Public price
CHF 4277.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2022

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
67862
Drug name
Retsevmo, gélules
Galenic form
KAHA
ATC Code
L01EX22
Authorization status
Z
Dispensing category
A
First authorization
08/02/2021
Authorization expiration date
19/12/2029
IT Number
07.16.1.
Domain
Human medicine

Package details

Description (FR)
RETSEVMO caps 80 mg 56 pce
Description (DE)
RETSEVMO Kaps 80 mg 56 Stk
Market launch
08/02/2021
Narcotic (BTM)
No

Other package sizes (5)

RETSEVMO caps 40 mg fl 60 pce
None None
GTIN: 7680678620019
Not in V1
RETSEVMO caps 40 mg 56 pce
56 KAP
GTIN: 7680678620040
View
RETSEVMO caps 80 mg fl 60 pce
None None
GTIN: 7680678620026
Not in V1
None
None None
GTIN: None
Not in V1
None
112 KAP
GTIN: None
Not in V1